These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8809342)

  • 1. Role of lipid aldehydes in cataractogenesis: 4-hydroxynonenal-induced cataract.
    Ansari NH; Wang L; Srivastava SK
    Biochem Mol Med; 1996 Jun; 58(1):25-30. PubMed ID: 8809342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.
    Lou MF; Xu GT; Zigler S; York B
    Curr Eye Res; 1996 Apr; 15(4):423-32. PubMed ID: 8670742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells.
    Spycher SE; Tabataba-Vakili S; O'Donnell VB; Palomba L; Azzi A
    FASEB J; 1997 Feb; 11(2):181-8. PubMed ID: 9039961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the aldose reductase inhibitor sorbinil on the isolated cultured rat lens.
    Yeh LA; Rafford CE; Beyer TA; Hutson NJ
    Metabolism; 1986 Apr; 35(4 Suppl 1):4-9. PubMed ID: 3083208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Sato S; Mori K; Wyman M; Kador PF
    Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of aldehyde dehydrogenase isozymes in the defense of rat lens and human lens epithelial cells against oxidative stress.
    Choudhary S; Xiao T; Vergara LA; Srivastava S; Nees D; Piatigorsky J; Ansari NH
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):259-67. PubMed ID: 15623782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of 4-hydroxynonenal-induced cataractogenesis in rat lens by butylated hydroxytoluene.
    Srivastata SK; Awasthi S; Wang L; Bhatnagar A; Awasthi YC; Ansari NH
    Curr Eye Res; 1996 Jul; 15(7):749-54. PubMed ID: 8670783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.
    Rittner HL; Hafner V; Klimiuk PA; Szweda LI; Goronzy JJ; Weyand CM
    J Clin Invest; 1999 Apr; 103(7):1007-13. PubMed ID: 10194473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
    Cheng HM; González RG
    Metabolism; 1986 Apr; 35(4 Suppl 1):10-4. PubMed ID: 3083198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M; Fukui H; Kuwabara T; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase.
    Srivastava S; Chandra A; Bhatnagar A; Srivastava SK; Ansari NH
    Biochem Biophys Res Commun; 1995 Dec; 217(3):741-6. PubMed ID: 8554593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E; Varagiannis E
    Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury.
    Ruef J; Liu SQ; Bode C; Tocchi M; Srivastava S; Runge MS; Bhatnagar A
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1745-52. PubMed ID: 10894812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells.
    Srivastava S; Conklin DJ; Liu SQ; Prakash N; Boor PJ; Srivastava SK; Bhatnagar A
    Atherosclerosis; 2001 Oct; 158(2):339-50. PubMed ID: 11583712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin protects against 4-hydroxy-2-trans-nonenal-induced cataract formation in rat lenses.
    Awasthi S; Srivatava SK; Piper JT; Singhal SS; Chaubey M; Awasthi YC
    Am J Clin Nutr; 1996 Nov; 64(5):761-6. PubMed ID: 8901798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
    Unakar NJ; Tsui JY
    Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N; Tsui J; Johnson M
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.